Login
CanSaRCC
Canadian Sarcoma Research and
Clinical Collaboration
Menu
Home
Overview
MemorialWall
About CanSaRCC
Team
Mentorship
Investigator Voices
Donate
Patient Support
Clinical Trials
Membership
Member Directory
Educational Events
Register
Login
Stimulating Outstanding Collaborations Between Clinicians And Scientists To Improve The Outcome of Sarcoma Patients
Learn More About CanSaRCC: A free registry to track tissues, blood samples and clinical data of Adults, Young Adults, Adolescents and Children with sarcoma across Canada
Overview
ABOUT Cansarcc
Investigator Voices
Mentorship
Team
Member Directory
Membership
Projects
Clinical Trials
Submit Project
Educational Forum
Educational Events
Patient Support
Memorial Wall
Register
Donate
Vision for Sarcoma Research & Clinical Trials - Hope for Sarcoma Patients
Nov 2025: Incidence, prevalence and treatment of patients with Epithelioid Haemangioendothelioma (EHE) in Canada
Epithelioid Haemangioendothelioma (EHE) is an ultra-rare sarcoma characterized by WWTR1- CAMTA1 or YAP1-TFE3 gene fus...
April 2025: Whole Abdominal Radiotherapy Is Tolerable and Effective in Children and Young Adults With Intra-Abdominal Sarcoma
Previous data describing WART for abdominal sarcoma is limited to small case series and literature specific to desmop...
April 2025: Local Control for Pediatric Rhabdomyosarcoma of the Extremities: Is Radiotherapy Always Required After Adequate Surgical Resection?
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and young adults. Typically, treatment invo...
May 2024: Real-World experience of tyrosine kinase inhibitors in patients with Desmoid-type-Fibromatosis
The use of Imatinib, Sorafenib and Pazopanib in the treatment of desmoid tumours has increased since the original tri...
Sep 2023: Real-World experience of tyrosine kinase inhibitors in children and adults patients with recurrent bone tumours
Patients with recurrent Ewing sarcoma, Chondrosarcoma or Osteosarcoma have very few treatment options. Recently, 2 tr...
Aug 2023: Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS)
Genetic predisposition, exposure to radiation and chemotherapy, chronic edema, chronic trauma and viral infections ar...
July 2023: The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas
Objective: The aim of the study is to describe the factors that influence outcome in adults with head and neck osteos...
April 2023: Radiation-Induced Sarcoma in Survivors of Childhood Cancer
Children with cancer often require radiation treatment (RT) in order to maximize chance of cure. However, RT can be a...
June 2022: Extra-Pleural Pneumonectomy (EPP) in Children and Adults With Advanced Sarcoma
Sarcoma can present as locally advanced disease involving the pleura for which extra-pulmonary pneumonectomy (EPP) is...
Nov 2019: High Prevalence of Persistent Emotional Distress in Desmoid Tumor
Clinical experience suggests a high prevalence of emotional distress in patients with aggressive fibromatosis (AF). T...
Contact Us
At cansarcc, we believe in fostering an environment where every voice is not only heard but also valued. Whether your questions revolve around the specifics of cansarcc, insights on our ongoing projects, or exploring potential partnerships, we are here to help! Together we navigate the complexities of sarcoma diagnosis and management by bringing together diverse perspectives and interests. Thank you for being apart of this journey.
Email:
[email protected]
Mailing Address:
Canadian Sarcoma Reseach and Clinircal Collaboration (CanSaRCC)
Princess Margaret
OPG, 700 University Avenue
7th floor, Room #7-714
Toronto, ON M5G 1Z5
Canada